Antipsychotics pharm Flashcards

1
Q

1st generation agents

A

-ChlorpromAZINE
-FluphenAZINE
-Haloperidol
-ThioridAZINE
-Thiothixene
(CFHTT)- azines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

2nd generation agents

A

-AriPIPRAZOLE
-ClozAPINE
-OlanzAPINE
-QuetiAPINE
-RisperIDONE
-ZiprasIDONE
(ACOQRZ)- prazole, apine, idone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

main diff b/w 1st and 2nd generation agents

A

-reduction in movement-disorder SE’s in 2nd gen!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Schizophrenia hypotheses

A

Dopamine hypothesis

  • direct/indirect DA-agonists provoke psychotic rxns in non-schizophrenics and exacerbate sx’s in schizophrenics
  • alterations in DA-mediated transmission in schizophrenics- inc DA occupancy of D2 R
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Dopamine Pathways relevant to schizophrenia sx’s

A
  • mesolimbic- + sx’s

- mesocortical- neg and cognitive sx’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mesolimbic pathway

A
  • VTA to NA
  • motivation, emotions, reward, + sx’s of schizophrenia
  • D2 antagonists reduce + sx’s of schizophrenia!!! (hallucinations, delusions, disorganized speech/thinking, agitation, abnormal motor behavior)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

mesocortical pathway

A
  • VTA to PFC (cortex)

- cognitive and negative sx’s (apathy, avolition, alogia, cognitive deficits, social withdrawal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Dopamine Pathway relevant to SE’s

A
  • Nigrostriatal- EPS and TD

- tuberoinfundibular- hyperprolactinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Nigrostriatal pathway

A
  • substantia nigra to striatum
  • purposeful movement
  • D2 antagonism induces extrapyramidal sx’s
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Tuberoinfundibular pathway

A
  • hypothalamus to infundibular region
  • dopamine inhibits prolactin release!!!
  • D2 antagonism inc PRL levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

1st gen antipsychotics- primarily do what?

A

(CFHTT- azines)

-block D2 post-synaptic R’s!!!- D2&raquo_space; 5HT2!!!!!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

FGA’s also block what?

A

other R’s- causing SE’s!!!

  • muscarinic
  • alpha-adrenergic
  • histamine
  • QTc prolongation and seizures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

muscarinic effects

A

(anti-cholinergic)

  • dry mouth
  • constipation
  • urinary retention
  • blurred vision
  • sedation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

alpha-adrenergic effects

A
  • orthostatic hypotension

- dizziness/syncope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

histamine effects

A

-sedation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

1st gen SE’s- dopamine effects

A
  • hyperprolactinemia- tuberoinfundibular pathway

- EPS (extrapyramidal sx’s)/ TD (tardive dyskinesia)- nigrostriatal pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Extrapyramidal sx’s- tx

A

(anticholinergic agents)

  • diphenhydramine
  • benztropine
  • trihexyphenidyl
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

1st gen- high EPS risk assoc with what?

A

-high D2 occupancy= high EPS risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

FGA’s- 2 categories

A
  • low potency- sedation, hypotension, seizure-threshold reduction- Chlorpromazine, Thioridazine
  • high potency- EPS and prolactin effects- Fluphenazine, Haloperidol, Thiothixene
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

2nd Gen antipsychotics- block what?

A
  • block D2 post-synaptic R’s
  • block 5HT2A
  • stronger 5HT2A R blockers than D2 R blockers!!!!
21
Q

2nd Gen antipsychotics- dual 5HT2A/D2 theory

A
  • 5HT2A antagonism inc DA transmission in nigrostriatal pathway- improved neg and cognitive sx’s via inc DA release in PFC
  • reduced EP SE’s
22
Q

SGA’s- additional info

A
  • rapidly dissociate from D2 R’s- reduced EP SE’s
  • D2 partial agonists- aripiprazole
  • 5HT1A full agonist (ziprasidone) and partial agonists (Aripiprazole, clozapine)
23
Q

SGA’s- SE’s?

A
Common:
-weight gain
-hyperglycemia, hyperlipidemia
Rare:
-QTc prolongation/ECG changes
-Stroke
24
Q

wt gain, diabetes, hypercholesterolemia- more common in?

A

-2nd gen!!!

25
EPS/TD, PRL elevation- more common in?
-1st gen!!!
26
Wt gain and diabetes- 1st gen
-Chlorpromazine!!
27
Wt gain and diabetes- 2nd gen
-no- aripiprazole, ziprasidone -yes- clozapine, olanzapine (more common in 2nd gen!!!)
28
Hypercholesterolemia- 1st gen
-Chlorpromazine!!!
29
Hypercholesterolemia- 2nd gen
- no- aripiprazole, ziprasidone | - yes- Clozapine, Olanzapine
30
EPS/TD- 1st gen
- all!! | - less- Chlorpromazine, Thioridazine
31
EPS/TD- 2nd gen
-yes- Risperidone
32
PRL elevation- 1st gen
-all!!
33
PRL elevation- 2nd gen
-Risperidone!!
34
Sedation- 1st gen
-Chlorpromazine, Thioridazine
35
Sedation- 2nd gen
-Clozapine, olanzapine, quetiapine
36
Anticholinergic SE's- 1st gen
-chlorpromazine, thioridazine
37
Anticholinergic SE's- 2nd gen
-yes- Clozapine
38
Orthostatic hypotension- 1st gen
-chlorpromazine, thioridazine
39
Orthostatic hypotension- 2nd gen
clozapine
40
QTc prolongation- 1st gen
-Thioridazine
41
QTc prolongation- 2nd gen
-Ziprasidone
42
2nd gen- rare but severe SE's
- agranulocytosis- clozapine- monitor WBC, REMS program!!!! - DRESS (drug rxn w eosinophilia and systemic sx's)- olanzapine - Neuroleptic malignant syndrome (parkinson's-like movement disorder w wide-spread m contraction)
43
Neuroleptic malignant syndrome- tx
-dantrolene!!- closes ryanodine R (Ca does not go in)
44
Antipsychotic monitoring
Baseline: - serum glucose - fasting lipid profile - weight (BMI) - BP - waist circumference - personal/family hx of metabolic and CV dz
45
more commonly used as 1st line?
-atypical agents!! (2nd gen)
46
Tx of psychotic disorders- LAIAS
(long-acting injectable agents)- used for non-adherence!!! - 1st gen- Haloperidol decanoate, Fluphenazine decanoate - 2nd gen- Risperidone, Olanzapine, Aripiprazole lauroxil, paliperidone palmitate (ROAP)
47
Tx of psychotic disorders- therapeutic pearls
-2-3 wks necessary to evaluate response to tx (maximum benefit- several months)
48
multi-drug resistant- tx?
-clozapine
49
psychotic w anti-suicidal thoughts/behaviors- tx?
-clozapine